Clinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes (Q42723596)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 2009
edit
Language Label Description Also known as
English
Clinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes
scientific article published on November 2009

    Statements

    Clinical pharmacology of alogliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of Type 2 diabetes (English)
    1 November 2009
    589-600

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit